uniQure acquires assets of Amsterdam Molecular Therapeutics - MarketLine Financial Deals

uniQure acquires assets of Amsterdam Molecular Therapeutics

uniQure acquires assets of Amsterdam Molecular Therapeutics - MarketLine Financial Deals
uniQure acquires assets of Amsterdam Molecular Therapeutics
Published Apr 05, 2012
4 pages — Published Apr 05, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

uniQure BV has acquired the assets and certain liabilities of Amsterdam Molecular Therapeutics.

  
Source:
Document ID
MA99033_120223
Country
Ticker
AMT=NL
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "uniQure acquires assets of Amsterdam Molecular Therapeutics" Apr 05, 2012. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/uniQure-acquires-assets-of-Amsterdam-Molecular-Therapeutics-2052-79885>
  
APA:
MarketLine Financial Deals. (2012). uniQure acquires assets of Amsterdam Molecular Therapeutics Apr 05, 2012. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/uniQure-acquires-assets-of-Amsterdam-Molecular-Therapeutics-2052-79885>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.